ARTIFICIAL INTELLIGENCE IN LIFE SCIENCES -
Life sciences companies are forming AI-driven strategic collaborations with tech giants, creating synergy that promises to revolutionize the industry. Companies like NVIDIA,...more
8/20/2024
/ Algorithms ,
America Invents Act ,
Artificial Intelligence ,
Bayh-Dole Act ,
Chevron Deference ,
Healthcare ,
Inflation Reduction Act (IRA) ,
Innovative Technology ,
Intellectual Property Protection ,
Life Sciences ,
Machine Learning ,
March-in-Rights ,
NIST ,
Non-Compete Agreements ,
Patents ,
Post-Grant Review ,
Prior Art ,
USPTO
The Inflation Reduction Act (IRA), signed into law in August 2022, impacted a wide range of tax laws and touched many aspects of government. Significantly, part of the IRA provides Medicare with the ability to negotiate the...more
7/21/2023
/ Artificial Intelligence ,
Benchmarking ,
Coronavirus/COVID-19 ,
Data Privacy ,
Data Protection ,
Department of Justice (DOJ) ,
Drug Pricing ,
Federal Trade Commission (FTC) ,
Inflation Reduction Act (IRA) ,
Intellectual Property Protection ,
Life Sciences ,
Non-Compete Agreements ,
Patent Litigation ,
Patent Trial and Appeal Board ,
Patents ,
Pharmaceutical Industry
Summary -
In Amgen v. Sanofi, the Supreme Court unanimously affirmed the District of Delaware and Federal Circuit findings that Amgen’s functionally defined patent claims to a class of therapeutic antibodies are invalid as...more
The U.S. Patent and Trademark Office (USPTO) last week established an updated patent fee schedule, effective January 16, 2018. The updated schedule provides for a modest increase for most fees—but also more significant...more
11/22/2017
/ Covered Business Method Patents ,
Design Patent ,
Fees ,
Filing Fees ,
Intellectual Property Protection ,
Inter Partes Review (IPR) Proceeding ,
Patent Applications ,
Patent Trial and Appeal Board ,
Patents ,
Post-Grant Review ,
USPTO ,
Utility Patents